AUS
NZ
UK
CA
USA
IND
Healt
Avita Medical (ASX:AVH) Reports Slower-Than-Expected Q4, Falling Short of Revenue Targets
January 08, 2025 11:51 AM AEDT| By Team Kalkine MediaHighlights:,Avita Medical's (AVH) Q4 revenue increases by,30%, but,falls below expectations.,The company lowers its full-year revenue projection for 2024.,Strong expectations for 2025 with a projected revenue growth of up to 60%.,Avita Medical (ASX:A...
Island Pharmaceuticals Advances ISLA-101 to Phase 2b Trial for Dengue Fever Treatment
January 08, 2025 11:40 AM AEDT| By Team Kalkine MediaHighlights:,Successful Subject Enrolment:,Island Pharmaceuticals Ltd (,ASX:ILA,) has,commenced,its Phase 2b clinical trial for ISLA-101, enrolling the first subjects to assess the drug's therapeutic potential against dengue fever.,Focus on Treatment...
Orthocell’s Revenue Surge: A Sustained Growth Story
January 08, 2025 11:27 AM AEDT| By Team Kalkine MediaHighlights:,Record Revenue Growth:,Orthocell,Ltd (,ASX:OCC,) reported A$2.21 million in revenue for Q4 FY2024, marking its third consecutive quarter of record-breaking results, with a 9% increase from the previous quarter.,Global Market Expansion:,Pr...
4DMedical Soars After FDA Approval for AI Diagnostic Tool
January 07, 2025 02:42 PM AEDT| By Team Kalkine MediaHighlights,4DMedical (4DX) receives FDA clearance for its IQ-UIP product.,The innovative technology improves diagnosis for Interstitial Pulmonary Fibrosis.,Shares rise 12.7% following the announcement.,Shares in 4DMedical (ASX:4DX), a leading respira...
Argent BioPharma Secures $4.5M to Advance Neuro-Immune and Nano-Medicine Drug Pipeline, Shares Jump 47%
January 07, 2025 12:15 PM AEDT| By Team Kalkine MediaHighlights,Capital Raise Completion:,Argent BioPharma successfully raises US$4.5 million through the issue of 11.25 million shares and warrants.,Strategic Focus:,Funds will advance the CannEpil® clinical studies and support the company’s transition t...
Dimerix Partners with FUSO to Advance Kidney Disease Treatment in Japan
January 07, 2025 12:02 PM AEDT| By Team Kalkine MediaHighlights,Strategic Partnership:,Dimerix has signed an exclusive agreement with Japan’s FUSO Pharmaceutical Industries Ltd for the development and commercialization of DMX-200 in Japan.,Major Financial Boost:,The deal includes up to ¥10.5 billion (A...
Dimerix Partners with FUSO for Kidney Disease Drug Development in Japan
January 07, 2025 11:06 AM AEDT| By Team Kalkine MediaHighlights,Strategic Partnership:,Dimerix,Ltd (,ASX:DXB,) collaborates with FUSO Pharmaceutical Industries to develop and commercialise DMX-200 for FSGS kidney disease in Japan.,Exclusive Rights:,FUSO secures exclusive development, registration, and...
Star Combo Pharma (ASX:S66): Examining the 30% Price Surge Amid Revenue Concerns
January 06, 2025 06:56 PM AEDT| By Team Kalkine MediaHighlights,Star Combo Pharma Limited's (S66) share price surged by 30% this month.,Medium-term revenue trends show a decline despite recent gains.,Price-to-sales ratio aligns with industry but raises questions about sustainability.,The share price of...
Biome Australia Reports Q2 FY2025 Sales Growth and Outperforms Market Expectations
January 06, 2025 03:13 PM AEDT| By Team Kalkine MediaHighlights,Q2 FY2025 Sales Revenue Exceeds Forecast: Biome Australia achieved ~$4.6 million in sales revenue for Q2 FY2025, surpassing the market forecast of $4.5 million, marking a solid quarter despite seasonal challenges.,Strong Annualized Run Rat...
Global Pharma Giants Advocate for Weight-Loss Drugs on PBS: A Push for Subsidised Solutions
January 06, 2025 11:35 AM AEDT| By Team Kalkine MediaHighlights,Mounjaro's,PBS Listing Push,: Eli Lilly aims to secure government subsidies for,Mounjaro,on the Pharmaceutical Benefits Scheme (PBS), targeting obesity-related health risks.,Economic and Healthcare Implications,: Advocates highlight potent...
Percheron Therapeutics Redirects Focus After Trial Results
January 06, 2025 11:24 AM AEDT| By Team Kalkine MediaHighlights,Percheron Therapeutics focuses on rebuilding after clinical trial outcomes.,The company explores diversification and pipeline expansion strategies.,Strategic review underway for future opportunities beyond Duchenne muscular dystrophy.,Perc...
Imugene Doses First Australian Patient in Phase 1b Azer-Cel Clinical Trial
January 03, 2025 12:00 AM AEDT| By Team Kalkine MediaHighlights:,Imugene (ASX:IMU) has commenced its Phase 1b clinical trial for azer-cel at Royal Prince Alfred Hospital in Sydney, marking a significant milestone in cancer treatment.,The trial will focus on patients with relapsed or refractory diffuse...
LTR Pharma secures national distribution agreement for its ED treatment with a major pharmacy.
January 02, 2025 11:00 AM AEDT| By Team Kalkine MediaHighlights:,Symbion to distribute Spontan, an innovative nasal spray for erectile dysfunction, across its extensive pharmacy network.,Collaboration supports LTR Pharma’s early access program and establishes a scalable distribution framework.,Spontan’...
Labor Plans Major Health Policy Overhaul Ahead of Federal Election
January 02, 2025 12:00 AM AEDT| By Team Kalkine MediaHighlights:,Labor intends to expand bulk billing, increase urgent care clinics, and reform GP subsidies under Medicare to alleviate healthcare costs.,Prime Minister Albanese's government will lift bulk billing incentives and implement changes to GP p...
The Expanding Potential of GLP-1 Drugs: A Transformative Medical Revolution
January 02, 2025 12:00 AM AEDT| By Team Kalkine MediaHighlight:,GLP-1 receptor agonists, like Ozempic and Wegovy, initially developed for diabetes and obesity, are now showing promise in treating a range of conditions including cardiovascular disease, chronic kidney disease, Alzheimer’s, and addiction....
Proteomics International’s OxiDx Test Demonstrates Breakthrough in Muscle Damage Recovery for Marathon Runners
December 31, 2024 12:36 PM AEDT| By Team Kalkine MediaHighlights,OxiDx test shows potential to identify muscle damage and assess recovery in elite marathon runners.,Study highlights the need for personalized recovery monitoring in high-performance sports.,The OxiDx test is set for Australian launch in H...
Advances in Biopharma: Kidney Imaging, Therapies, and Diagnostics
December 30, 2024 06:13 PM AEDT| By Team Kalkine MediaHighlights,Telix Pharmaceuticals (TLX) is advancing its kidney cancer imaging agent for potential US approval.,Dimerix (DXB) achieves a milestone in recruiting for its phase III kidney disease trial.,Proteomics International (PIQ) develops a highly a...
Imricor Medical Expands into Middle East with First Sales in Qatar, Shares Rise 8.55%
December 30, 2024 01:38 PM AEDT| By Team Kalkine MediaHighlights:,Imricor has secured its first purchase order for MRI-guided ablation equipment in Qatar.,The company is working with exclusive distributor East Agency WWL to introduce its iCMR labs to leading cardiac centres in Qatar.,Imricor’s share pri...
Proteomics International Shares Surge Nearly 20% on Monday. Here's Why.
December 30, 2024 01:23 PM AEDT| By Team Kalkine MediaHighlights,Proteomics International Laboratories unveils PromarkerEndo blood test, capable of diagnosing all stages of endometriosis with high accuracy.,The test’s breakthrough results, published in,Human Reproduction,, could revolutionize diagnosis,...
Goodman Group Surges Over 45% in 2024, Fueled by AI-Driven Data Centre Demand
December 30, 2024 11:43 AM AEDT| By Team Kalkine MediaHighlights,Goodman Group's stock rises over 45% in 2024, its best performance since 2006.,Data centres now make up 42% of Goodman’s AU$12.8 billion development pipeline.,Australia's data-centre market sees booming investment, led by global hyperscale...
Advertise your brand on Kalkine Media